DUBLIN--(BUSINESS WIRE)--Sep. 30, 2013--
plc (NYSE: COV) will report fourth-quarter results on November 8,
2013, before trading begins. The Company will hold a conference call for
investors at 8:30 a.m. ET. The call can be accessed in the following
At Covidien’s website: http://investor.covidien.com
By telephone: For both “listen-only” participants and those
participants who wish to take part in the question-and-answer portion
of the call, the telephone dial-in number in the U.S. is 877-280-4960.
For participants outside the U.S., the dial-in number is 857-244-7317.
The access code for all callers is 80544083.
Through an audio replay: A replay of the conference call will be
available beginning at 11:30 a.m. on November 8, 2013, and ending at
5:00 p.m. on November 15, 2013. The dial-in number for U.S.
participants is 888-286-8010. For participants outside the U.S., the
replay dial-in number is 617-801-6888. The replay access code for all
callers is 17727056.
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien manufactures,
distributes and services a diverse range of industry-leading products in
medical devices and supplies. With 2012 revenue of $9.9 billion,
Covidien has 38,000 employees worldwide in 70 countries, and its
products are sold in over 140 countries. Please visit www.covidien.com
to learn more about our business.
Source: Covidien plc
Jacqueline Strayer, 508-261-8305
Senior Vice President
Lannum, CFA, 508-452-4343